The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors.

CONCLUSIONS: The NETest exhibits clinically competent metrics as an effective biomarker for neuroendocrine tumors. Measurement of NET transcripts in blood is a significant advance in neuroendocrine tumor management and demonstrates that blood provides a viable source to identify and monitor tumor status.
PMID: 31841822 [PubMed - as supplied by publisher]

Source: Advances in Medical Sciences - December 12, 2019 Category: Biomedical Science Authors: Malczewska A, Kos-Kudła B, Kidd M, Drozdov I, Bodei L, Matar S, Oberg K, Modlin IM Tags: Adv Med Sci Source Type: research